SFC

ESC GUIDELINES 2022

  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal (2022) 00, 1–114 [DOI]
  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
    Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC) European Heart Journal (2022) 00, 1–133 [DOI]
  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
    Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) European Heart Journal (2022) 00, 1–99 [DOI]
  • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022. [DOI]

CARDIOLOGIE PEDIATRIQUE

  • Catheterization in Adults With Congenital Heart Disease
    A Primer for the Noncongenital Proceduralist [DOI]
  • Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association [AHA JOURNALS]
  • Sparking the Fire in Adult Congenital Heart Disease [DOI]
  • Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries [JACC]
  • Pulmonary Vein Stenosis – Balloon Angioplasty versus Stenting: A Systematic Review and Meta-Analysis [JACC]

CARDIO-ONCOLOGIE

  • Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. European journal of cancer , S0959-8049(22)00443-9. Advance online publication. [DOI]
  • Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis. Open heart, 9(2), e002053. [DOI]
  • Cardiac mechanics in response to proteasome inhibition: a prospective study. European heart journal. Cardiovascular Imaging, jeac168. Advance online publication. [DOI]
  • Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity. JACC. Cardiovascular imaging, 15(8), 1361–1376. [DOI]
  • Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease [JACC]
  • Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome [JACC]

CORONAIRES ET INTERVENTIONNEL

  • Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial [AHA JOURNALS]
  • Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials [AHA JOURNALS]
  • Hemodynamic Profiles and Clinical Response to Transcatheter Mitral Repair [JACC]
  • Deformation of Transcatheter Aortic Valve Prostheses: Implications for Hypoattenuating Leaflet Thickening and Clinical Outcomes [AHA JOURNALS]
  • Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial [AHA JOURNALS]
  • Balloon- vs Self-Expanding Valve Systems for Failed Small Surgical Aortic Valve Bioprostheses [JACC]
  • Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial [AHA JOURNALS]
  • The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR [JACC]
  • FFR-Guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: The FFR REACT Trial [JACC]
  • Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI [NEJM]
  • Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI [JACC]
  • Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction [NEJM]

HTA

  • Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations [AHA JOURNALS]
  • Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles [AHA JOURNALS]

IMAGERIE CARDIOVASCULAIRE

  • The quality of reporting in cardiac MRI artificial intelligence segmentation studies - a systematic review [ACADEMIC]
  • Myocardial fibrosis detection using kernel methods: preliminary results from a cardiac magnetic resonance study [ACADEMIC]
  • The utility of a fully automated cardiac magnetic resonance post-processing tool and radiomics algorithm to non-invasively classify patients with or without significant coronary artery stenosis [ACADEMIC]
  • Annotation and quality assessment of left ventricular filling and relaxation pattern using one-dimensional convolutional neural network [ACADEMIC]
  • Fully automatic AI-based valve motion parameter extraction on long axis CINE images - application on N=11000 patient datasets [ACADEMIC]
  • Prevalence and Prognostic Implications of Discordant Grading and Flow-Gradient Patterns in Moderate Aortic Stenosis [JACC]
  • SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association [AHA JOURNALS]
  • Improving the Characterization of Stage A and B Heart Failure by Adding Global Longitudinal Strain [JACC]
  • How to assess left ventricular filling pressures by echocardiography in clinical practice [ACADEMIC]
  • Quantification of left atrial fibrosis by 3D late gadolinium-enhanced cardiac magnetic resonance imaging in patients with atrial fibrillation: impact of different analysis methods [ACADEMIC]
  • Left atrial reservoir strain improves diagnostic accuracy of the 2016 ASE/EACVI diastolic algorithm in patients with preserved left ventricular ejection fraction: insights from the KARUM haemodynamic database [ACADEMIC]
  • Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance [ACADEMIC]
  • A concise history of echocardiography: timeline, pioneers, and landmark publications [ACADEMIC]
  • Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging [ACADEMIC]

INSUFFISANCE CARDIAQUE – CARDIOMYOPATHIES

  • Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction [JACC]
  • Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF [AHA JOURNALS]
  • Platypnea‐Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease [AHA JOURNALS]
  • Genetically Modified Porcine-to-Human Cardiac Xenotransplantation [NEJM]
  • The Future of Transplantation [NEJM]
  • Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association [AHA JOURNALS]
  • Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction [AHA JOURNALS]
  • Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled [ACADEMIC]
  • Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial [ACADEMIC]
  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction [NEJM]
  • Efficacy and Safety of Dapagliflozin According to Frailty in Patients with Heart Failure: A Prespecified Analysis of the DELIVER Trial [AHA JOURNALS]
  • Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes [AHA JOURNALS]

RISQUE CARDIOVASCULAIRE

  • Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function [JACC]
  • Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease [JACC]
  • Lessons from PURE on modifiable risk [ACADEMIC]
  • PDAY risk score predicts cardiovascular events in young adults: the CARDIA study [ACADEMIC]
  • Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes [NEJM]
  • Timing of cardiac surgery during pregnancy: a patient-level meta-analysis [ACADEMIC]
  • Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial [ACADEMIC]
  • Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial [JACC]
  • State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association [AHA JOURNALS]
  • Comparative Risks of Initial Aortic Events Associated With Genetic Thoracic Aortic Disease [JACC]
  • Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function [JACC]
  • Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review [JACC]
  • Polypill Strategy in Secondary Cardiovascular Prevention [NEJM]
  • Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab [AHA JOURNALS]
  • Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease [AHA JOURNALS]

RYTHMOLOGIE

  • Sex Differences in Atrial Fibrillation Risk. The VITAL Rhythm Study [JAMA NETWORK]
  • Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices [JAMA NETWORK]
  • Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease [JACC]
  • Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study [AHA JOURNALS]
  • Trends in survival after cardiac arrest: a Swedish nationwide study over 30 years [ACADEMIC]
  • Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden [AHA JOURNALS]
  • Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation [ACADEMIC]
  • Screening for Atrial Fibrillation in Asymptomatic Older Adults [NEJM]
  • Cardioneuroablation for reflex syncope: efficacy and effects on autonomic cardiac regulation- A Prospective Randomized Trial [JACC]
  • Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator [NEJM]
  • Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation [NEJM]
  • Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator [AHA JOURNALS]
  • Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator [ACADEMIC]
  • Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator [ACADEMIC]
  • Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond [ACADEMIC]

USIC

  • Routine Functional Testing or Standard Care in High-Risk Patients after PCI [NEJM]
  • Oxygen Targets in Comatose Survivors of Cardiac Arrest [NEJM]
  • Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest [NEJM]
  • Acetazolamide in Acute Decompensated Heart Failure with Volume Overload [NEJM]
  • Incidence, Characteristics, and Outcomes of Ventricular Fibrillation Complicating Acute Myocardial Infarction in Women Admitted Alive in the Hospital [AHA JOURNALS]
  • Importance of genetic testing in unexplained cardiac arrest [ACADEMIC]

VALVULOPATHIES

  • Management of Patients With Severe Mitral Annular Calcification: JACC State-of-the-Art Review [JACC]
  • Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week [JACC]
  • Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey [ACADEMIC]
  • Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease [ACADEMIC]
  • Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial [ACADEMIC]
  • Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry [ACADEMIC]
  • Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? [ACADEMIC]
  • Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease [JACC]
  • Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure [JACC]
  • Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR: From the ALIGN-TAVR Consortium [JACC]
  • Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes: A Systematic Review and Meta-Analysis [JACC]
  • The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis [ACADEMIC]
  • Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy [JACC]

COVID

  • Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age [NEJM]
  • Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review [JACC]
  • Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 [NEJM]
  • Covid-19 Vaccines — Immunity, Variants, Boosters [NEJM]
  • Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT [AHA JOURNALS]
  • Annual mortality related to pulmonary embolism in the US before and during the COVID-19 pandemic [JACC]
  • Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge [NEJM]

LA FRANCE A L’HONNEUR

  • Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey [ACADEMIC]
  • Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial [ACADEMIC]
  • Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry [ACADEMIC]
  • Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR: From the ALIGN-TAVR Consortium [JACC]
  • Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial Substudy [JACC]

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !